GPC1 and pancreatic neoplasm: In addition, glypican-1(GPC1) in serum EVs is significantly increased in patients with pancreatic cancer, and even in patients with precancerous lesions, suggesting the great potential of GPC1 in EVs for the early diagnosis of pancreatic cancer [18].